Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05139030 · ClinicalTrials.gov registry record · Phase 3
Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty
A Phase 3 study of Knee Osteoarthritis and Pain Management, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 167
- Enrollment target
- 6
- Study locations
NCT05139030 is a Phase 3 study of Knee Osteoarthritis and Pain Management that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 167 participants, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (45% lower). The trial reports 6 study locations across 4 states.
The verdict
NCT05139030, a Phase 3 study of Knee Osteoarthritis and Pain Management, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 167 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of the study is to compare magnitude of postsurgical analgesic effect in different groups following a single dose of study drug when administered via adductor canal block in subjects undergoing primary unilateral total knee arthroplasty.
Conditions Studied
Interventions
- DRUG Bupivacaine Hydrochloride
- DRUG bupivacaine liposome injectable suspension
Study Locations (6)
Texas
- First Surgical Hospital - Bellaire
- HD Research- Legent Orthopedic Hospital - Carrollton
- Endeavor Clinical Trials - San Antonio
Arkansas
- Woodland International Research Group - Little Rock
California
- Lotus Clinical Research - Pasadena
Ohio
- Midwest Clinical Research Center, LLC - Dayton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2022-01-18 |
| Est. Completion | 2022-07-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05139030
The ClinicalTrials.gov registry entry for NCT05139030 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (45% lower). The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Knee Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Bupivacaine Hydrochloride is the first listed.
NCT05139030 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Texas, Arkansas, California.
Frequently Asked Questions
What is clinical trial NCT05139030 about?
NCT05139030 is a clinical study titled "Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty". The purpose of the study is to compare magnitude of postsurgical analgesic effect in different groups following a single dose of study drug when administered via adductor canal block in subjects undergoing primary unilateral total knee arthroplasty.
What is the current status of trial NCT05139030?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 167 participants. The study started on 2022-01-18. Estimated completion is 2022-07-11.
What conditions does trial NCT05139030 study?
This clinical trial studies the following conditions: Knee Osteoarthritis, Pain Management.
What interventions are being tested in trial NCT05139030?
The interventions under investigation include: Bupivacaine Hydrochloride (DRUG), bupivacaine liposome injectable suspension (DRUG).
Who is sponsoring clinical trial NCT05139030?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05139030 being conducted?
This trial has 6 study locations across Arkansas, California, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dronabinol After Arthroscopic Surgery
RECRUITING · Phase 3
-
Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 3
-
Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee
COMPLETED · Phase 3
-
Microfragmented Adipose Tissue Compared to Corticosteroid Injection for the Treatment of Knee Osteoarthritis
COMPLETED · Phase 3
-
Patient-Reported Outcomes in Evaluating Lorecivivint (SM04690) for Moderate to Severe Knee Osteoarthritis (STRIDES-1)
COMPLETED · Phase 3
-
Evaluating Changes in Synovial Fluid Before and After GAE for Knee Osteoarthritis
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.